Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
85.218,87
1,01%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Skye Bioscience Inc (SKYE) Skye Bioscience Inc (SKYE) Notizie

SKYE

Skye Bioscience (SKYE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SKYE
DataOraFonteTitoloSimboloCompagnia
01/03/202500:54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SKYESkye Bioscience Inc
27/02/202501:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SKYESkye Bioscience Inc
26/02/202523:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SKYESkye Bioscience Inc
20/12/202400:09Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:SKYESkye Bioscience Inc
15/11/202423:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SKYESkye Bioscience Inc
14/11/202415:21Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SKYESkye Bioscience Inc
07/11/202422:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SKYESkye Bioscience Inc
07/11/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SKYESkye Bioscience Inc
23/09/202423:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SKYESkye Bioscience Inc
13/09/202423:18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SKYESkye Bioscience Inc
04/09/202423:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SKYESkye Bioscience Inc
24/07/202413:30GlobeNewswire Inc.Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for ObesityNASDAQ:SKYESkye Bioscience Inc
20/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SKYESkye Bioscience Inc
17/05/202422:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SKYESkye Bioscience Inc
10/05/202422:19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SKYESkye Bioscience Inc
17/06/201015:00MarketwiredMarshall Edwards Announces Additional Management Changes With Appointment of New Chief Financial OfficerNASDAQ:SKYESkye Bioscience Inc
25/03/201008:16MarketwiredSkyePharma PLC announces Final ResultsNASDAQ:SKYESkye Bioscience Inc
21/01/201016:59MarketwiredSkyepharma PLC announces - Regulatory UpdateNASDAQ:SKYESkye Bioscience Inc
18/11/200908:00MarketwiredSkyepharma PLC - Board ChangeNASDAQ:SKYESkye Bioscience Inc
12/11/200908:00MarketwiredSkyepharma PLC - Interim Management StatementNASDAQ:SKYESkye Bioscience Inc
02/11/200911:23MarketwiredFlutiform EU Clinical Trial Successfully CompletedNASDAQ:SKYESkye Bioscience Inc
01/09/200908:00MarketwiredSKYEPHARMA PLC - Research UpdateNASDAQ:SKYESkye Bioscience Inc
22/06/200916:42MarketwiredSkyepharma PLC announces Conversion of BondsNASDAQ:SKYESkye Bioscience Inc
09/06/200916:14MarketwiredSkyepharma PLC Announces Research UpdateNASDAQ:SKYESkye Bioscience Inc
22/05/200908:09MarketwiredSkyePharma PLC: Flutiform NDA Accepted for ReviewNASDAQ:SKYESkye Bioscience Inc
15/05/200908:03MarketwiredSkyepharma PLC announces Board AppointmentNASDAQ:SKYESkye Bioscience Inc
15/05/200908:00MarketwiredSkyepharma Announces Interim Management StatementNASDAQ:SKYESkye Bioscience Inc
31/03/200908:17MarketwiredSkyepharma - Re AgreementNASDAQ:SKYESkye Bioscience Inc
26/03/200908:05MarketwiredSkyepharma PLC Announces Final ResultsNASDAQ:SKYESkye Bioscience Inc
23/03/200908:00MarketwiredSkyepharma PLC Announces Regulatory ApplicationNASDAQ:SKYESkye Bioscience Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SKYE

La tua Cronologia

BIT
ENI
Eni
BIT
UCG
Unicredit
BIT
NEXI
Nexi S.p.A
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
LDO
Leonardo
BIT
PRY
Prysmian
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
MONC
Moncler
BIT
BAMI
Banco BPM
BIT
FCT
Fincantieri
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci